Lupus

Among the culprits: sunlight, cigarettes, and oral contraceptives.

What underlies the disparity in life expectancy between men and women with SLE?

The goal: to find a treatment target that protects against damage accrual in the early stages of SLE.

Obese patients report higher disease activity, more depressive symptoms, and greater pain and fatigue.

There’s a higher risk of total organ damage and end-stage renal disease in patients with SLE.

Up-to-date guidelines were developed to help improve patient outcomes.

Study findings highlight the need for physicians to heed the symptoms of testosterone deficiency.

LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.

For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.

There are few tests to accurately assess the degree and effects of lupus in children, but Ped-ANAM proves to be a promising option.

Lupus patients who receive healthcare at more than one location face a greater risk of infection and comorbidities, research shows.

Doctor and patients perceive the importance of lupus medications differently. In this article, we feature a UAB-derived decision aid that highlights key considerations.

Diagnosed with systemic lupus erythematosus and chikungunya, a woman embarks on a cross-continent trip for treatment and diagnosis at a city hospital.

The lack of progress in new treatments for lupus nephritis summarized in this scientific review.

Cryptococcal meningitis infections in systemic lupus erythematosus (SLE) patients often go misdiagnosed, researchers find.

Age and cumulative glucocorticoid exposure are key risk factors for low bone mineral density in systemic lupus erythematosus.

For high risk patients with systemic lupus erythematosus, teriparatide and denosumab may be an option for patients who have failed bisphosphonates. Here are some key points you need to know.

Bone loss could affect as many as 31 percent of SLE patients. This article sums up the treatment options from first-line bisphosphonate recommendations to emerging treatments like abaloparatide.

In this Q&A, Rheumatology Network speaks with Dr. Barbara Vilen who is making strides in both basic and translational research that may lead to new therapeutic targets for lupus.

In this Q&A, Rheumatology Network speaks with Dr. Stephen Katz about the NIAMS Action Plan for Lupus Research.

In patients with CNS lupus, early evidence shows the presence of the development of dementia, says Dr. Yehuda Shoenfeld of Israel. "Lupus is a disease of young females, so it's not elderly females with dementia at this age."

The little-understood antibody immunoglobulin E (IgE) plays a previously unknown role in systemic lupus erythematosus, study in Nature Immunology finds.

Women may be far more likely than men to be diagnosed with SLE, but research suggests that at diagnosis, men with the disease may be worse off.

To be young and African-American with a connective tissue disease, such as rheumatoid arthritis, means possibly facing a greater risk of developing some types of heart disease.

Anemia could increase the prevalence of restless legs syndrome in patients with lupus.